nodes	percent_of_prediction	percent_of_DWPC	metapath
Penicillamine—SLCO1B1—Methotrexate—testicular cancer	0.0254	1	CbGbCtD
Penicillamine—Extravasation—Doxorubicin—testicular cancer	0.00232	0.00238	CcSEcCtD
Penicillamine—Decreased appetite—Chlorambucil—testicular cancer	0.00231	0.00237	CcSEcCtD
Penicillamine—Tinnitus—Ifosfamide—testicular cancer	0.00231	0.00237	CcSEcCtD
Penicillamine—Leukopenia—Bleomycin—testicular cancer	0.00226	0.00232	CcSEcCtD
Penicillamine—Hepatobiliary disease—Cisplatin—testicular cancer	0.00225	0.00231	CcSEcCtD
Penicillamine—Angiopathy—Ifosfamide—testicular cancer	0.00225	0.00231	CcSEcCtD
Penicillamine—Glossitis—Doxorubicin—testicular cancer	0.00219	0.00225	CcSEcCtD
Penicillamine—Aplastic anaemia—Methotrexate—testicular cancer	0.00219	0.00225	CcSEcCtD
Penicillamine—Alopecia—Ifosfamide—testicular cancer	0.00219	0.00225	CcSEcCtD
Penicillamine—Anaemia—Dactinomycin—testicular cancer	0.00217	0.00223	CcSEcCtD
Penicillamine—Mental disorder—Ifosfamide—testicular cancer	0.00217	0.00223	CcSEcCtD
Penicillamine—Renal failure—Etoposide—testicular cancer	0.00214	0.0022	CcSEcCtD
Penicillamine—Neuropathy peripheral—Etoposide—testicular cancer	0.00214	0.00219	CcSEcCtD
Penicillamine—Stomatitis—Etoposide—testicular cancer	0.00212	0.00218	CcSEcCtD
Penicillamine—Decreased appetite—Vinblastine—testicular cancer	0.00212	0.00217	CcSEcCtD
Penicillamine—Urticaria—Chlorambucil—testicular cancer	0.00211	0.00217	CcSEcCtD
Penicillamine—Mouth ulceration—Methotrexate—testicular cancer	0.00211	0.00216	CcSEcCtD
Penicillamine—Urinary tract disorder—Cisplatin—testicular cancer	0.00211	0.00216	CcSEcCtD
Penicillamine—Leukopenia—Dactinomycin—testicular cancer	0.00211	0.00216	CcSEcCtD
Penicillamine—Body temperature increased—Chlorambucil—testicular cancer	0.0021	0.00216	CcSEcCtD
Penicillamine—Urethral disorder—Cisplatin—testicular cancer	0.00209	0.00215	CcSEcCtD
Penicillamine—Hepatobiliary disease—Etoposide—testicular cancer	0.00206	0.00211	CcSEcCtD
Penicillamine—Aplastic anaemia—Epirubicin—testicular cancer	0.00205	0.0021	CcSEcCtD
Penicillamine—Neuropathy—Epirubicin—testicular cancer	0.00205	0.0021	CcSEcCtD
Penicillamine—Agranulocytosis—Etoposide—testicular cancer	0.00203	0.00209	CcSEcCtD
Penicillamine—Thrombocytopenia—Bleomycin—testicular cancer	0.00202	0.00207	CcSEcCtD
Penicillamine—Anaemia—Ifosfamide—testicular cancer	0.00199	0.00204	CcSEcCtD
Penicillamine—Tinnitus—Cisplatin—testicular cancer	0.00199	0.00204	CcSEcCtD
Penicillamine—Lymphadenopathy—Methotrexate—testicular cancer	0.00199	0.00204	CcSEcCtD
Penicillamine—Agitation—Ifosfamide—testicular cancer	0.00198	0.00203	CcSEcCtD
Penicillamine—Mouth ulceration—Epirubicin—testicular cancer	0.00197	0.00203	CcSEcCtD
Penicillamine—Anorexia—Bleomycin—testicular cancer	0.00196	0.00201	CcSEcCtD
Penicillamine—Hypersensitivity—Chlorambucil—testicular cancer	0.00196	0.00201	CcSEcCtD
Penicillamine—Thrombophlebitis—Methotrexate—testicular cancer	0.00196	0.00201	CcSEcCtD
Penicillamine—Urinary tract disorder—Etoposide—testicular cancer	0.00193	0.00198	CcSEcCtD
Penicillamine—Leukopenia—Ifosfamide—testicular cancer	0.00193	0.00198	CcSEcCtD
Penicillamine—Urethral disorder—Etoposide—testicular cancer	0.00192	0.00197	CcSEcCtD
Penicillamine—Aplastic anaemia—Doxorubicin—testicular cancer	0.0019	0.00195	CcSEcCtD
Penicillamine—Neuropathy—Doxorubicin—testicular cancer	0.0019	0.00195	CcSEcCtD
Penicillamine—Alopecia—Cisplatin—testicular cancer	0.00189	0.00194	CcSEcCtD
Penicillamine—Hepatic failure—Methotrexate—testicular cancer	0.00188	0.00193	CcSEcCtD
Penicillamine—Thrombocytopenia—Dactinomycin—testicular cancer	0.00188	0.00193	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.00188	0.00192	CcSEcCtD
Penicillamine—Lymphadenopathy—Epirubicin—testicular cancer	0.00186	0.00191	CcSEcCtD
Penicillamine—Arthralgia—Ifosfamide—testicular cancer	0.00184	0.00188	CcSEcCtD
Penicillamine—Thrombophlebitis—Epirubicin—testicular cancer	0.00183	0.00188	CcSEcCtD
Penicillamine—Anorexia—Dactinomycin—testicular cancer	0.00183	0.00188	CcSEcCtD
Penicillamine—Mouth ulceration—Doxorubicin—testicular cancer	0.00183	0.00187	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.00182	0.00187	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Epirubicin—testicular cancer	0.00182	0.00187	CcSEcCtD
Penicillamine—Diarrhoea—Chlorambucil—testicular cancer	0.00182	0.00187	CcSEcCtD
Penicillamine—Hepatic function abnormal—Epirubicin—testicular cancer	0.00181	0.00186	CcSEcCtD
Penicillamine—Hypersensitivity—Vinblastine—testicular cancer	0.0018	0.00184	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Methotrexate—testicular cancer	0.0018	0.00184	CcSEcCtD
Penicillamine—Decreased appetite—Bleomycin—testicular cancer	0.00179	0.00184	CcSEcCtD
Penicillamine—Angiopathy—Etoposide—testicular cancer	0.00177	0.00182	CcSEcCtD
Penicillamine—Hepatic failure—Epirubicin—testicular cancer	0.00176	0.00181	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.00175	0.0018	CcSEcCtD
Penicillamine—Alopecia—Etoposide—testicular cancer	0.00173	0.00177	CcSEcCtD
Penicillamine—Thrombocytopenia—Ifosfamide—testicular cancer	0.00172	0.00177	CcSEcCtD
Penicillamine—Lymphadenopathy—Doxorubicin—testicular cancer	0.00172	0.00176	CcSEcCtD
Penicillamine—Anaemia—Cisplatin—testicular cancer	0.00172	0.00176	CcSEcCtD
Penicillamine—Skin disorder—Ifosfamide—testicular cancer	0.00171	0.00175	CcSEcCtD
Penicillamine—Thrombophlebitis—Doxorubicin—testicular cancer	0.00169	0.00174	CcSEcCtD
Penicillamine—Vomiting—Chlorambucil—testicular cancer	0.00169	0.00174	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Doxorubicin—testicular cancer	0.00169	0.00173	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Epirubicin—testicular cancer	0.00168	0.00172	CcSEcCtD
Penicillamine—Hepatic function abnormal—Doxorubicin—testicular cancer	0.00168	0.00172	CcSEcCtD
Penicillamine—Anorexia—Ifosfamide—testicular cancer	0.00168	0.00172	CcSEcCtD
Penicillamine—Decreased appetite—Dactinomycin—testicular cancer	0.00167	0.00171	CcSEcCtD
Penicillamine—Diarrhoea—Vinblastine—testicular cancer	0.00167	0.00171	CcSEcCtD
Penicillamine—Dysgeusia—Etoposide—testicular cancer	0.00167	0.00171	CcSEcCtD
Penicillamine—Leukopenia—Cisplatin—testicular cancer	0.00166	0.00171	CcSEcCtD
Penicillamine—Urticaria—Bleomycin—testicular cancer	0.00164	0.00168	CcSEcCtD
Penicillamine—Hepatic failure—Doxorubicin—testicular cancer	0.00163	0.00167	CcSEcCtD
Penicillamine—Body temperature increased—Bleomycin—testicular cancer	0.00163	0.00167	CcSEcCtD
Penicillamine—Hypoglycaemia—Epirubicin—testicular cancer	0.00162	0.00167	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.0016	0.00164	CcSEcCtD
Penicillamine—Nausea—Chlorambucil—testicular cancer	0.00158	0.00162	CcSEcCtD
Penicillamine—Anxiety—Cisplatin—testicular cancer	0.00158	0.00162	CcSEcCtD
Penicillamine—Anaemia—Etoposide—testicular cancer	0.00157	0.00161	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.00157	0.00161	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.00155	0.00159	CcSEcCtD
Penicillamine—Vomiting—Vinblastine—testicular cancer	0.00155	0.00159	CcSEcCtD
Penicillamine—Decreased appetite—Ifosfamide—testicular cancer	0.00153	0.00157	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.00153	0.00156	CcSEcCtD
Penicillamine—Leukopenia—Etoposide—testicular cancer	0.00152	0.00156	CcSEcCtD
Penicillamine—Body temperature increased—Dactinomycin—testicular cancer	0.00152	0.00156	CcSEcCtD
Penicillamine—Hypersensitivity—Bleomycin—testicular cancer	0.00152	0.00156	CcSEcCtD
Penicillamine—Hypoglycaemia—Doxorubicin—testicular cancer	0.0015	0.00154	CcSEcCtD
Penicillamine—Thrombocytopenia—Cisplatin—testicular cancer	0.00149	0.00152	CcSEcCtD
Penicillamine—Skin disorder—Cisplatin—testicular cancer	0.00147	0.00151	CcSEcCtD
Penicillamine—Asthma—Methotrexate—testicular cancer	0.00146	0.0015	CcSEcCtD
Penicillamine—Eosinophilia—Methotrexate—testicular cancer	0.00145	0.00149	CcSEcCtD
Penicillamine—Nausea—Vinblastine—testicular cancer	0.00145	0.00149	CcSEcCtD
Penicillamine—Abdominal pain upper—Epirubicin—testicular cancer	0.00145	0.00149	CcSEcCtD
Penicillamine—Anorexia—Cisplatin—testicular cancer	0.00145	0.00148	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00144	0.00148	CcSEcCtD
Penicillamine—Pancreatitis—Methotrexate—testicular cancer	0.00144	0.00147	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.00143	0.00146	CcSEcCtD
Penicillamine—Hypersensitivity—Dactinomycin—testicular cancer	0.00141	0.00145	CcSEcCtD
Penicillamine—Muscular weakness—Epirubicin—testicular cancer	0.0014	0.00143	CcSEcCtD
Penicillamine—Urticaria—Ifosfamide—testicular cancer	0.0014	0.00143	CcSEcCtD
Penicillamine—Body temperature increased—Ifosfamide—testicular cancer	0.00139	0.00143	CcSEcCtD
Penicillamine—Pancytopenia—Methotrexate—testicular cancer	0.00139	0.00143	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00138	0.00142	CcSEcCtD
Penicillamine—Asthma—Epirubicin—testicular cancer	0.00137	0.00141	CcSEcCtD
Penicillamine—Thrombocytopenia—Etoposide—testicular cancer	0.00136	0.0014	CcSEcCtD
Penicillamine—Eosinophilia—Epirubicin—testicular cancer	0.00136	0.00139	CcSEcCtD
Penicillamine—Skin disorder—Etoposide—testicular cancer	0.00135	0.00139	CcSEcCtD
Penicillamine—Pancreatitis—Epirubicin—testicular cancer	0.00134	0.00138	CcSEcCtD
Penicillamine—Abdominal pain upper—Doxorubicin—testicular cancer	0.00134	0.00137	CcSEcCtD
Penicillamine—Anorexia—Etoposide—testicular cancer	0.00132	0.00136	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.00132	0.00136	CcSEcCtD
Penicillamine—Decreased appetite—Cisplatin—testicular cancer	0.00132	0.00135	CcSEcCtD
Penicillamine—Diarrhoea—Dactinomycin—testicular cancer	0.00131	0.00135	CcSEcCtD
Penicillamine—Vomiting—Bleomycin—testicular cancer	0.00131	0.00134	CcSEcCtD
Penicillamine—Pancytopenia—Epirubicin—testicular cancer	0.0013	0.00133	CcSEcCtD
Penicillamine—Rash—Bleomycin—testicular cancer	0.0013	0.00133	CcSEcCtD
Penicillamine—Dermatitis—Bleomycin—testicular cancer	0.0013	0.00133	CcSEcCtD
Penicillamine—Hypersensitivity—Ifosfamide—testicular cancer	0.0013	0.00133	CcSEcCtD
Penicillamine—Muscular weakness—Doxorubicin—testicular cancer	0.00129	0.00133	CcSEcCtD
Penicillamine—Renal failure—Methotrexate—testicular cancer	0.00128	0.00132	CcSEcCtD
Penicillamine—Stomatitis—Methotrexate—testicular cancer	0.00127	0.00131	CcSEcCtD
Penicillamine—Asthma—Doxorubicin—testicular cancer	0.00127	0.0013	CcSEcCtD
Penicillamine—Eosinophilia—Doxorubicin—testicular cancer	0.00126	0.00129	CcSEcCtD
Penicillamine—Haematuria—Methotrexate—testicular cancer	0.00124	0.00128	CcSEcCtD
Penicillamine—Pancreatitis—Doxorubicin—testicular cancer	0.00124	0.00128	CcSEcCtD
Penicillamine—Hepatobiliary disease—Methotrexate—testicular cancer	0.00123	0.00127	CcSEcCtD
Penicillamine—Nausea—Bleomycin—testicular cancer	0.00122	0.00125	CcSEcCtD
Penicillamine—Vomiting—Dactinomycin—testicular cancer	0.00122	0.00125	CcSEcCtD
Penicillamine—Agranulocytosis—Methotrexate—testicular cancer	0.00122	0.00125	CcSEcCtD
Penicillamine—Rash—Dactinomycin—testicular cancer	0.00121	0.00124	CcSEcCtD
Penicillamine—Decreased appetite—Etoposide—testicular cancer	0.00121	0.00124	CcSEcCtD
Penicillamine—Diarrhoea—Ifosfamide—testicular cancer	0.0012	0.00124	CcSEcCtD
Penicillamine—Pancytopenia—Doxorubicin—testicular cancer	0.0012	0.00124	CcSEcCtD
Penicillamine—Renal failure—Epirubicin—testicular cancer	0.0012	0.00123	CcSEcCtD
Penicillamine—Body temperature increased—Cisplatin—testicular cancer	0.0012	0.00123	CcSEcCtD
Penicillamine—Neuropathy peripheral—Epirubicin—testicular cancer	0.0012	0.00123	CcSEcCtD
Penicillamine—Stomatitis—Epirubicin—testicular cancer	0.00119	0.00122	CcSEcCtD
Penicillamine—Haemoglobin—Methotrexate—testicular cancer	0.00118	0.00121	CcSEcCtD
Penicillamine—Haemorrhage—Methotrexate—testicular cancer	0.00117	0.0012	CcSEcCtD
Penicillamine—Haematuria—Epirubicin—testicular cancer	0.00116	0.0012	CcSEcCtD
Penicillamine—Urinary tract disorder—Methotrexate—testicular cancer	0.00116	0.00119	CcSEcCtD
Penicillamine—Hepatobiliary disease—Epirubicin—testicular cancer	0.00116	0.00119	CcSEcCtD
Penicillamine—Urethral disorder—Methotrexate—testicular cancer	0.00115	0.00118	CcSEcCtD
Penicillamine—Nausea—Dactinomycin—testicular cancer	0.00114	0.00117	CcSEcCtD
Penicillamine—Agranulocytosis—Epirubicin—testicular cancer	0.00114	0.00117	CcSEcCtD
Penicillamine—Vomiting—Ifosfamide—testicular cancer	0.00112	0.00115	CcSEcCtD
Penicillamine—Hypersensitivity—Cisplatin—testicular cancer	0.00112	0.00115	CcSEcCtD
Penicillamine—Renal failure—Doxorubicin—testicular cancer	0.00111	0.00114	CcSEcCtD
Penicillamine—Rash—Ifosfamide—testicular cancer	0.00111	0.00114	CcSEcCtD
Penicillamine—Dermatitis—Ifosfamide—testicular cancer	0.00111	0.00114	CcSEcCtD
Penicillamine—Neuropathy peripheral—Doxorubicin—testicular cancer	0.00111	0.00114	CcSEcCtD
Penicillamine—Urticaria—Etoposide—testicular cancer	0.0011	0.00113	CcSEcCtD
Penicillamine—Haemoglobin—Epirubicin—testicular cancer	0.0011	0.00113	CcSEcCtD
Penicillamine—Stomatitis—Doxorubicin—testicular cancer	0.0011	0.00113	CcSEcCtD
Penicillamine—Body temperature increased—Etoposide—testicular cancer	0.0011	0.00113	CcSEcCtD
Penicillamine—Haemorrhage—Epirubicin—testicular cancer	0.0011	0.00113	CcSEcCtD
Penicillamine—Tinnitus—Methotrexate—testicular cancer	0.00109	0.00112	CcSEcCtD
Penicillamine—Urinary tract disorder—Epirubicin—testicular cancer	0.00108	0.00111	CcSEcCtD
Penicillamine—Haematuria—Doxorubicin—testicular cancer	0.00108	0.00111	CcSEcCtD
Penicillamine—Urethral disorder—Epirubicin—testicular cancer	0.00107	0.0011	CcSEcCtD
Penicillamine—Hepatobiliary disease—Doxorubicin—testicular cancer	0.00107	0.0011	CcSEcCtD
Penicillamine—Angiopathy—Methotrexate—testicular cancer	0.00106	0.00109	CcSEcCtD
Penicillamine—Agranulocytosis—Doxorubicin—testicular cancer	0.00105	0.00108	CcSEcCtD
Penicillamine—Nausea—Ifosfamide—testicular cancer	0.00105	0.00107	CcSEcCtD
Penicillamine—Diarrhoea—Cisplatin—testicular cancer	0.00104	0.00107	CcSEcCtD
Penicillamine—Alopecia—Methotrexate—testicular cancer	0.00104	0.00106	CcSEcCtD
Penicillamine—Mental disorder—Methotrexate—testicular cancer	0.00103	0.00105	CcSEcCtD
Penicillamine—Hypersensitivity—Etoposide—testicular cancer	0.00102	0.00105	CcSEcCtD
Penicillamine—Tinnitus—Epirubicin—testicular cancer	0.00102	0.00105	CcSEcCtD
Penicillamine—Haemoglobin—Doxorubicin—testicular cancer	0.00102	0.00105	CcSEcCtD
Penicillamine—Haemorrhage—Doxorubicin—testicular cancer	0.00101	0.00104	CcSEcCtD
Penicillamine—Urinary tract disorder—Doxorubicin—testicular cancer	0.001	0.00103	CcSEcCtD
Penicillamine—Dysgeusia—Methotrexate—testicular cancer	0.000999	0.00102	CcSEcCtD
Penicillamine—Angiopathy—Epirubicin—testicular cancer	0.000995	0.00102	CcSEcCtD
Penicillamine—Urethral disorder—Doxorubicin—testicular cancer	0.000995	0.00102	CcSEcCtD
Penicillamine—Alopecia—Epirubicin—testicular cancer	0.000969	0.000994	CcSEcCtD
Penicillamine—Vomiting—Cisplatin—testicular cancer	0.000965	0.00099	CcSEcCtD
Penicillamine—Mental disorder—Epirubicin—testicular cancer	0.000961	0.000986	CcSEcCtD
Penicillamine—Rash—Cisplatin—testicular cancer	0.000957	0.000981	CcSEcCtD
Penicillamine—Dermatitis—Cisplatin—testicular cancer	0.000956	0.000981	CcSEcCtD
Penicillamine—Diarrhoea—Etoposide—testicular cancer	0.000951	0.000976	CcSEcCtD
Penicillamine—Tinnitus—Doxorubicin—testicular cancer	0.000946	0.000971	CcSEcCtD
Penicillamine—Anaemia—Methotrexate—testicular cancer	0.000943	0.000967	CcSEcCtD
Penicillamine—Dysgeusia—Epirubicin—testicular cancer	0.000935	0.000959	CcSEcCtD
Penicillamine—Angiopathy—Doxorubicin—testicular cancer	0.000921	0.000945	CcSEcCtD
Penicillamine—Leukopenia—Methotrexate—testicular cancer	0.000913	0.000937	CcSEcCtD
Penicillamine—Nausea—Cisplatin—testicular cancer	0.000901	0.000925	CcSEcCtD
Penicillamine—Alopecia—Doxorubicin—testicular cancer	0.000897	0.00092	CcSEcCtD
Penicillamine—Mental disorder—Doxorubicin—testicular cancer	0.000889	0.000912	CcSEcCtD
Penicillamine—Vomiting—Etoposide—testicular cancer	0.000884	0.000907	CcSEcCtD
Penicillamine—Anaemia—Epirubicin—testicular cancer	0.000882	0.000905	CcSEcCtD
Penicillamine—Agitation—Epirubicin—testicular cancer	0.000877	0.0009	CcSEcCtD
Penicillamine—Rash—Etoposide—testicular cancer	0.000876	0.000899	CcSEcCtD
Penicillamine—Dermatitis—Etoposide—testicular cancer	0.000875	0.000898	CcSEcCtD
Penicillamine—Arthralgia—Methotrexate—testicular cancer	0.000868	0.000891	CcSEcCtD
Penicillamine—Dysgeusia—Doxorubicin—testicular cancer	0.000865	0.000887	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000862	0.000885	CcSEcCtD
Penicillamine—Leukopenia—Epirubicin—testicular cancer	0.000854	0.000877	CcSEcCtD
Penicillamine—Nausea—Etoposide—testicular cancer	0.000826	0.000847	CcSEcCtD
Penicillamine—Anaemia—Doxorubicin—testicular cancer	0.000816	0.000838	CcSEcCtD
Penicillamine—Thrombocytopenia—Methotrexate—testicular cancer	0.000815	0.000836	CcSEcCtD
Penicillamine—Arthralgia—Epirubicin—testicular cancer	0.000813	0.000834	CcSEcCtD
Penicillamine—Agitation—Doxorubicin—testicular cancer	0.000812	0.000833	CcSEcCtD
Penicillamine—Anxiety—Epirubicin—testicular cancer	0.00081	0.000831	CcSEcCtD
Penicillamine—Skin disorder—Methotrexate—testicular cancer	0.000809	0.00083	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000807	0.000828	CcSEcCtD
Penicillamine—Anorexia—Methotrexate—testicular cancer	0.000794	0.000814	CcSEcCtD
Penicillamine—Leukopenia—Doxorubicin—testicular cancer	0.000791	0.000811	CcSEcCtD
Penicillamine—Thrombocytopenia—Epirubicin—testicular cancer	0.000763	0.000783	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000758	0.000778	CcSEcCtD
Penicillamine—Skin disorder—Epirubicin—testicular cancer	0.000757	0.000776	CcSEcCtD
Penicillamine—Arthralgia—Doxorubicin—testicular cancer	0.000752	0.000772	CcSEcCtD
Penicillamine—Anxiety—Doxorubicin—testicular cancer	0.000749	0.000769	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000747	0.000766	CcSEcCtD
Penicillamine—Anorexia—Epirubicin—testicular cancer	0.000743	0.000762	CcSEcCtD
Penicillamine—Decreased appetite—Methotrexate—testicular cancer	0.000724	0.000743	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.00071	0.000728	CcSEcCtD
Penicillamine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000706	0.000724	CcSEcCtD
Penicillamine—Skin disorder—Doxorubicin—testicular cancer	0.0007	0.000718	CcSEcCtD
Penicillamine—Anorexia—Doxorubicin—testicular cancer	0.000687	0.000705	CcSEcCtD
Penicillamine—Decreased appetite—Epirubicin—testicular cancer	0.000677	0.000695	CcSEcCtD
Penicillamine—Urticaria—Methotrexate—testicular cancer	0.000661	0.000679	CcSEcCtD
Penicillamine—Body temperature increased—Methotrexate—testicular cancer	0.000658	0.000675	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000657	0.000674	CcSEcCtD
Penicillamine—Decreased appetite—Doxorubicin—testicular cancer	0.000627	0.000643	CcSEcCtD
Penicillamine—Urticaria—Epirubicin—testicular cancer	0.000619	0.000635	CcSEcCtD
Penicillamine—Body temperature increased—Epirubicin—testicular cancer	0.000616	0.000632	CcSEcCtD
Penicillamine—Hypersensitivity—Methotrexate—testicular cancer	0.000613	0.000629	CcSEcCtD
Penicillamine—Hypersensitivity—Epirubicin—testicular cancer	0.000574	0.000589	CcSEcCtD
Penicillamine—Urticaria—Doxorubicin—testicular cancer	0.000573	0.000588	CcSEcCtD
Penicillamine—Body temperature increased—Doxorubicin—testicular cancer	0.00057	0.000585	CcSEcCtD
Penicillamine—Diarrhoea—Methotrexate—testicular cancer	0.00057	0.000584	CcSEcCtD
Penicillamine—Diarrhoea—Epirubicin—testicular cancer	0.000533	0.000547	CcSEcCtD
Penicillamine—Hypersensitivity—Doxorubicin—testicular cancer	0.000531	0.000545	CcSEcCtD
Penicillamine—Vomiting—Methotrexate—testicular cancer	0.000529	0.000543	CcSEcCtD
Penicillamine—Rash—Methotrexate—testicular cancer	0.000525	0.000539	CcSEcCtD
Penicillamine—Dermatitis—Methotrexate—testicular cancer	0.000524	0.000538	CcSEcCtD
Penicillamine—Vomiting—Epirubicin—testicular cancer	0.000495	0.000508	CcSEcCtD
Penicillamine—Nausea—Methotrexate—testicular cancer	0.000494	0.000507	CcSEcCtD
Penicillamine—Diarrhoea—Doxorubicin—testicular cancer	0.000493	0.000506	CcSEcCtD
Penicillamine—Rash—Epirubicin—testicular cancer	0.000491	0.000504	CcSEcCtD
Penicillamine—Dermatitis—Epirubicin—testicular cancer	0.000491	0.000504	CcSEcCtD
Penicillamine—Nausea—Epirubicin—testicular cancer	0.000463	0.000475	CcSEcCtD
Penicillamine—Vomiting—Doxorubicin—testicular cancer	0.000458	0.00047	CcSEcCtD
Penicillamine—Rash—Doxorubicin—testicular cancer	0.000455	0.000466	CcSEcCtD
Penicillamine—Dermatitis—Doxorubicin—testicular cancer	0.000454	0.000466	CcSEcCtD
Penicillamine—Nausea—Doxorubicin—testicular cancer	0.000428	0.000439	CcSEcCtD
